Precigen, Inc. (PGEN) Stock Forecast
PGEN analyst forecast
as of October 18, 2026- Analyst consensus
- Buy 4.25 / 5 from 4 analysts
- Price target
- $13.65 average of analyst targets
- Upside to target
- +113.6% from the latest close
- Next earnings
- November 12, 2026 EPS estimate $0.09
- 52-week range
- $3.10 – $8.56
PGEN analyst ratings
4 analystsNumber of analysts at each rating.
PGEN price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
PGEN earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.08 | $0.05 | $0.14 | −$1.06 | +107.7% | 4 |
| Current fiscal year (2026) | $0.22 | $0.14 | $0.38 | −$1.37 | +116.3% | 4 |
| Next fiscal year (2027) | $0.63 | $0.29 | $1.32 | $0.22 | +184.8% | 4 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
PGEN revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $72.3M | $59.6M | $87.0M | +2,374.6% | 4 |
| Current fiscal year (2026) | $238.8M | $204.2M | $285.3M | +2,365.7% | 4 |
| Next fiscal year (2027) | $443.5M | $306.8M | $694.0M | +85.8% | 4 |
PGEN EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
PGEN revenue: reported and forecast
PGEN EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.00 | −$0.00 | $0.08 | $0.08 | $0.08 | −2,563.6% | 0 up · 0 down |
| Current fiscal year (2026) | −$0.03 | −$0.03 | $0.22 | $0.22 | $0.22 | −842.3% | 0 up · 0 down |
| Next fiscal year (2027) | $0.20 | $0.20 | $0.68 | $0.68 | $0.63 | +217.1% | 2 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
PGEN earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; PGEN beat in 7 of 12.
What analysts expect from PGEN
4 analysts cover Precigen; their consensus rating is buy (4.25 on a 1–5 scale, where 5 is a strong buy). The average price target is $13.65, 113.6% above the latest close of $6.39. Analysts expect earnings of $0.22 per share for 2026, +116.3% from a year earlier. For 2027 the average estimate is $0.63 per share on revenue of $443.5 million. Precigen beat the EPS estimate in 7 of the last 12 quarters.
Related: PGEN income statement, PGEN key metrics, PGEN chart. See the PGEN stock overview for the latest quote and news.
PGEN forecast FAQ
What is Precigen's price target?
The average analyst price target for Precigen is $13.65, 113.6% above the latest close of $6.39.
Is Precigen a buy, hold or sell?
Of 4 analysts covering Precigen, 2 rate it a strong buy, 1 a buy, 1 a hold, 0 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Precigen's EPS forecast?
Analysts forecast $0.22 per share for 2026 (range $0.14 to $0.38); for 2027 the estimate is $0.63.
What is Precigen's revenue forecast?
The average revenue estimate for 2026 is $238.8 million, growth of 2,365.7%; for 2027 it is $443.5 million.
When does Precigen report earnings?
Precigen is expected to report results for the quarter ending September 30, 2026 on November 12, 2026 after the market closes; the EPS estimate is $0.09.
Does Precigen usually beat earnings estimates?
Precigen reported EPS at or above the analyst estimate in 7 of the last 12 quarters.